May 13, 2021
LuMind IDSC’s Chief Scientific Officer, James Hendrix, and a team of dedicated researchers and clinicians have published a key manuscript from the Down Syndrome Clinical Trial Network (DS-CTN) using early data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study. This cross-curricular, multi-institutional effort is an important step in preparing the Down syndrome community, and those who research them, for clinical trial readiness.